title: Aminophylline modulation of the mouse respiratory network changes during postnatal maturation.
abstract: Aminophylline is a respiratory stimulant commonly used for the treatment of central apnea. Experiences from clinical practice, however, revealed that aminophylline is not reliably effective in preterm infants, whereas it is normally effective in infants and mature patients. In an established animal model for postnatal development of respiratory control mechanisms, we therefore examined the hypothesis that the clinical observations reflect a developmental change in the sensitivity of the central respiratory network to methylxanthines. The medullary respiratory network was isolated at different postnatal ages (postnatal days 1-13; P1-P13) in a transverse mouse brain stem slice preparation. This preparation contains the pre-Bötzinger complex (PBC), a region that is critical for generation of respiratory rhythm. Spontaneous rhythmic respiratory activity was recorded from the hypoglossal (XII) rootlets and from neurons in the PBC by using the whole cell patch clamp technique. Bath-applied aminophylline [20 microM] increased the frequency (+41%) in neonatal animals (P1-P6) without affecting the amplitude of respiratory burst activity in XII rootlets. The same concentration of aminophylline did not have any significant effect on the frequency of respiratory XII bursts but increased the amplitude (+31%) in juvenile animals (P7-P13). In the same age group, aminophylline also augmented the amplitude and the duration of respiratory synaptic drive currents in respiratory PBC neurons. The data demonstrate that augmentation of the respiratory output is due to direct enhancement of central respiratory network activity and increase of synaptic drive of hypoglossal motoneurons in juvenile, but not neonatal, animals. This indicates a developmental change in the efficacy of aminophylline to reinforce central respiratory network activity. Therefore, we believe that the variable success in treating respiratory disturbances in premature infants reflects maturational changes in the expression of receptors and/or intracellular signal pathways in the central respiratory network.
authors.affiliation: II. Department of Physiology, University of Göttingen, 37073 Göttingen, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Wilken
authors.forename: J M
authors.initials: JM
authors.lastname: Ramirez
authors.forename: F
authors.initials: F
authors.lastname: Hanefeld
authors.forename: D W
authors.initials: DW
authors.lastname: Richter
mesh_terms: D000367:Age Factors; D000628:Aminophylline / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D001049:Apnea / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000494:pharmacology*; D005260:Female; D007002:Hypoglossal Nerve / Q000254:growth & development / Q000502:physiology; D008297:Male; D051379:Mice; D009924:Organ Culture Techniques; D012125:Respiratory Center / Q000187:drug effects* / Q000254:growth & development*; D015656:Respiratory Mechanics / Q000187:drug effects / Q000502:physiology
chemical_list: D001993:Bronchodilator Agents; D000628:Aminophylline